Fulgent Genetics (FLGT) Notes Payables (2020 - 2026)

Fulgent Genetics has disclosed Notes Payables across 7 years of filings, most recently posting $482000.0 for Q2 2026.

• In Q2 2026, Notes Payables rose 1.26% year-over-year to $482000.0; the TTM figure through Jun 2026 stood at $482000.0 (up 1.26% YoY), while the FY2025 annual figure was $476000.0, up 15.53% from the prior year.
• Notes Payables came in at $482000.0 for Q2 2026 at Fulgent Genetics, roughly flat from $482000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $6.1 million in Q1 2022 to a low of $412000.0 in Q2 2024.
• Average Notes Payables over 5 years is $2.3 million, with a median of $482000.0 recorded in 2026.
• Year-over-year, Notes Payables surged 909.23% in 2022 and plunged 92.64% in 2024.
• Over 5 years, Notes Payables stood at $5.6 million in 2022, then tumbled by 79.02% to $1.2 million in 2023, then plunged by 65.17% to $412000.0 in 2024, then grew by 15.53% to $476000.0 in 2025, then increased by 1.26% to $482000.0 in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $482000.0 in Q2 2026, $482000.0 in Q1 2026, and $476000.0 in Q4 2025.